Category: Pharmaceuticals - Page 2

Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge 26 Jan 2026
Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge

Europe adopted biosimilars early with clear rules and high adoption. The US lagged due to patents and regulatory hurdles-but is now catching up fast. Here's how the two markets differ and why it matters for patients and costs.

Long-term Safety of Generic vs Brand Drugs: What the Data Really Shows 21 Jan 2026
Long-term Safety of Generic vs Brand Drugs: What the Data Really Shows

Long-term safety studies show generics are generally as safe as brand drugs, but critical exceptions exist - especially for narrow therapeutic index medications. Manufacturer, origin, and individual response matter more than brand vs generic labels.

How to Prevent Early Refills and Duplicate Therapy Mistakes in Pharmacy Practice 19 Jan 2026
How to Prevent Early Refills and Duplicate Therapy Mistakes in Pharmacy Practice

Learn how to stop dangerous early refills and duplicate therapy mistakes in pharmacy practice using proven protocols, EHR tools, and staff training to improve medication safety and prevent overdose risks.

Antiemetics and Cardiac Risks: Understanding QT Prolongation and Drowsiness 17 Jan 2026
Antiemetics and Cardiac Risks: Understanding QT Prolongation and Drowsiness

Not all antiemetics are safe for everyone. Some can dangerously prolong the QT interval or cause severe drowsiness. Learn which drugs carry the highest cardiac risks and how to choose safer alternatives for nausea and vomiting.

Tizanidine and Ciprofloxacin: Why This Drug Combo Can Cause Dangerous Low Blood Pressure and Extreme Drowsiness 14 Jan 2026
Tizanidine and Ciprofloxacin: Why This Drug Combo Can Cause Dangerous Low Blood Pressure and Extreme Drowsiness

Combining tizanidine and ciprofloxacin can cause dangerous drops in blood pressure and extreme drowsiness due to a powerful drug interaction. Learn why this combo is risky and what to do instead.

Bioequivalent medications: what the term really means 11 Jan 2026
Bioequivalent medications: what the term really means

Bioequivalent medications are generic drugs proven to work the same as brand-name versions in the body. Learn how regulators test for equivalence, when it matters, and what you should know before switching.

Anticholinergic Burden in Older Adults: How Common Medications Increase Dementia Risk 8 Jan 2026
Anticholinergic Burden in Older Adults: How Common Medications Increase Dementia Risk

Common medications like Benadryl and oxybutynin can build up anticholinergic burden in older adults, increasing dementia risk. Learn which drugs are dangerous, how they affect the brain, and what safer alternatives exist.

180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Shapes Drug Prices 7 Jan 2026
180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Shapes Drug Prices

180-day exclusivity under the Hatch-Waxman Act gives the first generic drug challenger a temporary monopoly to incentivize patent challenges. But delays in market entry can block competition for years, keeping prices high for patients.

Addressing Patient Concerns About Biosimilars: Reducing Hesitation and Building Trust 5 Jan 2026
Addressing Patient Concerns About Biosimilars: Reducing Hesitation and Building Trust

Biosimilars offer major cost savings and proven safety, but patient hesitation remains high due to misinformation and lack of transparency. Learn how to understand biosimilars, address concerns, and make informed decisions with your doctor.

Insurance Formulary Tiers Explained: Tier 1, Tier 2, Tier 3, and Non-Formulary Drugs 27 Dec 2025
Insurance Formulary Tiers Explained: Tier 1, Tier 2, Tier 3, and Non-Formulary Drugs

Understand how insurance formulary tiers work-Tier 1, Tier 2, Tier 3, and non-formulary drugs-and how they affect your prescription costs. Learn what to do when your drug is too expensive.